Company profile: Minimally Invasive Devices
1.1 - Company Overview
Company description
- Provider of minimally invasive surgical tools, notably the FloShield system to enhance laparoscopic visualization. Products include FloShield Plus and FloShield Air using Vortex Barrier Technology to direct dry CO2 for continuous defogging and protection from condensation, debris, and smoke, and Flo-X in situ for intra-operative lens cleaning with a biocompatible surfactant without scope removal.
Products and services
- FloShield Air: Continuous-defogging system employing Vortex Barrier Technology to keep laparoscope lenses clear of condensation, debris, and smoke, delivering protection and visibility without scope removal during laparoscopic surgery
- FloShield Plus: Integrated system combining Vortex Barrier Technology with Flo-X in situ, actively preventing lens contamination and enabling intra-operative cleaning with a biocompatible surfactant without removing the scope
- Vortex Barrier Technology: CO2-based system that directs a continuous flow of dry CO2 gas over the laparoscope tip, instantly defogging and shielding against condensation, debris, and smoke during laparoscopic procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Minimally Invasive Devices
Neo Medical
HQ: Switzerland
Website
- Description: Provider of medtech solutions to achieve a more Functional Fusion in spinal surgery, aiming to transform the current approach with efficient, versatile, and high-quality systems that address healthcare cost optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neo Medical company profile →
Obsidio
HQ: United States
Website
- Description: Provider of a biomaterial platform technology for minimally-invasive occlusion of blood vessels anywhere in the body, usable regardless of patient coagulopathy to control bleeding and close off vessels supplying blood to tumor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Obsidio company profile →
NX Development
HQ: United States
Website
- Description: Provider of real-time intra-operative imaging agents. Offers Gleolan, an optical imaging agent used during brain tumor resection to visualize malignant tissue, and Phase 3 studies assessing Gleolan for detecting and visualizing meningiomas (MEN-301) and investigating its real-time detection and visualization of ovarian cancer during debulking surgery (OVA-302).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NX Development company profile →
7D Surgical
HQ: Canada
Website
- Description: Provider of cost-effective, radiation-free, machine-vision image-guided navigation for spine and cranial surgeries. The FLASH Navigation System uses visible light and special cameras to create 3D reconstructions for rapid, accurate navigation, with FLASH Fix for quick re-registration and FLASH Trajectory for real-time implant sizing and virtual screw trajectories; also develops optical technologies and registration algorithms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 7D Surgical company profile →
Genicon
HQ: United States
Website
- Description: Provider of patented surgical instrumentation, engaged in design, production, and distribution; recognized as an emerging leader.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genicon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Minimally Invasive Devices
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Minimally Invasive Devices
2.2 - Growth funds investing in similar companies to Minimally Invasive Devices
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Minimally Invasive Devices
4.2 - Public trading comparable groups for Minimally Invasive Devices
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →